Our internationally recognized pediatric hematologists/oncologists and hematopathologists are world leaders in diagnosing and treating all types of pediatric blood cancers. In addition to treating lymphomas and leukemias, our pediatric hematologists/oncologists also treat histiocytosis, which is not a form of cancer but shares some of the characteristics of cancer and is often treated by pediatric hematologist/oncologists using some of the same therapies.
Andrew E. Place, MD, PhD
Co-Director of the Hematologic Malignancy Center (Clinical Service & Clinical Research)
Relapsed and refractory leukemia
Kimberly Stegmaier, MD
Co-Director of the Hematologic Malignancy Center (Basic & Translational Research)
Kimberly J. Davies, MD
Hodgkin lymphoma, Non-Hodgkin's lymphoma
Barbara A. Degar, MD
Acute myeloid leukemia (AML), Langerhans cell histiocytosis (LCH), hemophagocytic lymphohistiocytosis (HLH)
Jennifer C. Kesselheim, MD, M.Ed
All types of leukemia and lymphoma, medical education
Jessica A. Pollard, MD
Myelodysplastic syndrome (MDS), myeloid malignancies
Lewis B. Silverman, MD
Acute lymphoblastic leukemia (ALL)
Lynda M. Vrooman, MD
Cancer survivorship and late effects of cancer treatment
(in alphabetical order)
Phone: 617-632-5508Online form: Request an appointment
U.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.
Stephen Sallan, MD, describes symptoms, diagnosis and treatment for acute lymphoblastic leukemia (ALL) in children.
Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.